Recently, lncRNA cancer susceptibility 9 (CASC9) was found to be significantly upregulated in GBM tissues and its ectopic high expression was associated with poor survival, which acted as an independent prognostic factor for GBM patients [200]. The gene discussed is CASC9; the disease is glioblastoma.